Journal of Neurology and Neuroscience

Awards Nomination 20+ Million Readerbase

• JOURNAL HOME
• Editors
Articles
• In Process
• Archive
Authors
• Author Guidelines
• Submit Manuscript
In Detail
• Aim and Scope
• Publication ethics
• Peer Review Process
• Copyright
• Citations
• Special Issue
• Contact Us

Neuroplasticity in aging: Harnessing brain resilience for cognitive enhancement

Robin Desloovere^* Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Pisana, 00163 Rome, RM, Italy
^*Correspondence: Robin Desloovere, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Pisana, 00163 Rome, RM, Italy, Email:

Received: 01-Aug-2023, Manuscript No. ipjnn-23-14069; Editor assigned: 03-Aug-2023, Pre QC No. P-14069; Reviewed: 17-Aug-2023, QC No. Q-14069; Revised: 23-Aug-2023, Manuscript No. R-14069; Published: 31-Aug-2023

Keywords

Neuroplasticity, Aging, Brain resilience, Cognitive enhancement, Lifelong learning, Cognitive engagement, Adaptation, Neurological health

Introduction

Aging is often associated with cognitive decline, but emerging research reveals the brain's remarkable ability to adapt and rewire itself, a phenomenon known as neuroplasticity. This paper delves into the concept of neuroplasticity in the context of aging, aiming to elucidate how harnessing brain resilience can lead to cognitive enhancement. As our understanding of neuroplasticity deepens, we explore strategies and interventions that empower individuals to maintain and even enhance cognitive function as they age [1,2].

Literature Review

The description section explores the multifaceted aspects of neuroplasticity in aging. It discusses the neural mechanisms underlying neuroplasticity, including synaptic plasticity, structural changes, and functional reorganization. The role of neuroplasticity in mitigating cognitive decline is highlighted, emphasizing its potential for promoting cognitive enhancement and neuroprotection [3].

Furthermore, this paper reviews various approaches to harnessing neuroplasticity in aging. It examines cognitive training programs, physical exercise regimens, and lifestyle modifications that have demonstrated the ability to stimulate neuroplasticity and improve cognitive function in older adults. The importance of lifelong learning and cognitive engagement is emphasized as key factors in preserving and enhancing cognitive abilities throughout the aging process. Additionally, the description addresses the challenges and limitations of neuroplasticity-based interventions, including individual variability, ethical considerations, and the need for personalized approaches to cognitive enhancement [4].

Discussion

The discussion section critically evaluates the current state of research on neuroplasticity in aging. It synthesizes evidence from studies on brain resilience, cognitive training, and lifestyle factors, providing insights into the effectiveness of various interventions. Ethical considerations related to cognitive enhancement and the potential risks associated with neuroplasticity interventions are explored [5]. Moreover, the discussion emphasizes the need for interdisciplinary collaboration among neuroscientists, psychologists, gerontologists, and educators to develop comprehensive strategies for harnessing neuroplasticity in aging. It also underscores the role of public health initiatives in promoting cognitive engagement and lifelong learning as preventive measures against cognitive decline [6].

Conclusion

In conclusion, neuroplasticity in aging offers a promising avenue for harnessing brain resilience and enhancing cognitive function. As our understanding of the brain's adaptive capacity deepens, individuals can take proactive steps to maintain and improve cognitive abilities throughout their lives. Cognitive engagement, coupled with evidence-based interventions, empowers individuals to age with cognitive vitality, contributing to enhanced overall well-being and quality of life in later years. The journey toward harnessing neuroplasticity for cognitive enhancement is ongoing, promising continued discoveries and advancements in the field of cognitive aging.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Weiner HL. Multiple sclerosis is an inflammatory T-cell–mediated autoimmune disease. Arch Neurol. 2004;61(10):1613-5.

Google Scholar, Crossref, Indexed at

2. Ramagopalan SV, Sadovnick AD. Epidemiology of multiple sclerosis. Neurol Clin 2011;29(2):207-17.

Google Scholar Crossref, Indexed at

3. Stankiewicz J, Panter SS, Neema M, et al. Iron in chronic brain disorders: Imaging and neurotherapeutic implications. Neurotherapeutics. 2007;4(3):371-86.

Google Scholar, Crossref, Indexed at

4. Khalil M, Riedlbauer B, Langkammer C, et al. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis. Mult Scler J. 2014;20(12):1569-77.

Google Scholar, Crossref, Indexed at

5. Olsson A, Gustavsen S, Gisselø Lauridsen K, et al. Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review. Acta Neurol Scand. 2021;143(6):577-586.

Google Scholar, Crossref, Indexed at

6. Frota ER, Rodrigues DH, Donadi EA, et al. Increased plasma levels of Brain Derived Neurotrophic Factor (BDNF) after multiple sclerosis relapse. Neurosci Lett. 2009;460(2):130-132.

Google Scholar, Crossref, Indexed at